Exact Mass: 424.1514
Exact Mass Matches: 424.1514
Found 312 metabolites which its exact mass value is equals to given mass value 424.1514
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Eprosartan
Eprosartan is an angiotensin II receptor antagonist used for the treatment of high blood pressure. It acts on the renin-angiotensin system in two ways to decrease total peripheral resistance. First, it blocks the binding of angiotensin II to AT1 receptors in vascular smooth muscle, causing vascular dilatation. Second, it inhibits sympathetic norepinephrine production, further reducing blood pressure. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D057912 - Angiotensin II Type 2 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 2776 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Eprosartan (SKF-108566J free base) is a selective, competitive, nonpeptid and orally active angiotensin II receptor antagonist, used as an antihypertensive. Eprosartan binds angiotensin II receptor with IC50s of 9.2 nM and 3.9 nM in rat and human adrenal cortical membranes, respectively [1].
6-Hydroxymelatonin glucuronide
6-Hydroxymelatonin glucuronide is a metabolite of melatonin. Melatonin Listen/ˌmɛləˈtoʊnɪn/, also known chemically as N-acetyl-5-methoxytryptamine, is a naturally occurring compound found in animals, plants, and microbes. In animals, circulating levels of the hormone melatonin vary in a daily cycle, thereby allowing the entrainment of the circadian rhythms of several biological functions. (Wikipedia)
4-[[2-Butyl-5-(2-carboxy-3-thiophen-2-ylprop-1-enyl)-1-imidazolyl]methyl]benzoic acid
methyl 2-((2,2-dimethylchroman-6-yl)methyl)-4-hydroxy-3-(4-hydroxyphenyl)-5-oxo-2,5-dihydrofuran-2-carboxylate
7,8,3,4-Tetramethoxy-6,6-dimethylpyrano[2,3:5,6]flavone
(+)-tephropurpurin
1,5,6-trihydroxy-7-methoxy-6,6-dimethyl-2H-pyrano (2,3:3,2)-4-(3,3-dimethylprop-2-enyl) xanthone
2-hydroxy-4-[4-hydroxyphenyl-(4-hydroxy-3-methoxybenzyl)]-3-(3,5-dihydroxyphenyl)tetrahydrofuran|pouzolignan A
2,4,5,5-tetramethoxy-2,2-dimethylpyrano<6,5-h>isoflavone|2,4,5,5-Tetramethoxy-2,2-dimethylpyrano-<6,5-h>isoflavone|5-Methoxy-8,8-dimethyl-3-(2,4,5-trimethoxy-phenyl)-8H-pyrano[2,3-f]chromen-4-on|5-methoxy-8,8-dimethyl-3-(2,4,5-trimethoxy-phenyl)-8H-pyrano[2,3-f]chromen-4-one|5-methoxybarbigerone|toxicarol
O-(3-Hydroxymethyl-2-butenyl)-3-[(4-Hydroxyphenyl)methyl]-1,4-dimethyl-3,6-bis(methylthio)-2,5-piperazinedione
angeloyl beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside|everlastoside F
12-(1,1-dimethylallyl)-5,7,9-trihydroxy-10-methoxy-2,2-dimethyl-2H-pyrano[3,2-b]xanthen-6-one|linixanthone A
C24H24O7_Methyl (2R)-4-hydroxy-2-[4-hydroxy-3-(3-methyl-2-buten-1-yl)benzyl]-3-(4-hydroxyphenyl)-5-oxo-2,5-dihydro-2-furancarboxylate
Ala Cys Met Thr
Ala Cys Thr Met
Ala Asp Gly Tyr
Ala Asp Tyr Gly
Ala Gly Asp Tyr
Ala Gly Tyr Asp
Ala Met Cys Thr
Ala Met Thr Cys
Ala Thr Cys Met
Ala Thr Met Cys
Ala Tyr Asp Gly
Ala Tyr Gly Asp
Cys Ala Met Thr
Cys Ala Thr Met
Cys Cys Ile Ser
Cys Cys Leu Ser
Cys Cys Ser Ile
Cys Cys Ser Leu
Cys Cys Thr Val
Cys Cys Val Thr
Cys Ile Cys Ser
Cys Ile Ser Cys
Cys Leu Cys Ser
Cys Leu Ser Cys
Cys Met Ala Thr
Cys Met Thr Ala
Cys Ser Cys Ile
Cys Ser Cys Leu
Cys Ser Ile Cys
Cys Ser Leu Cys
Cys Thr Ala Met
Cys Thr Cys Val
Cys Thr Met Ala
Cys Thr Val Cys
Cys Val Cys Thr
Cys Val Thr Cys
Asp Ala Gly Tyr
Asp Ala Tyr Gly
Asp Phe Gly Ser
Asp Phe Ser Gly
Asp Gly Ala Tyr
Asp Gly Phe Ser
Asp Gly Ser Phe
Asp Gly Tyr Ala
Asp Ser Phe Gly
Asp Ser Gly Phe
Asp Tyr Ala Gly
Asp Tyr Gly Ala
Glu Gly Gly Tyr
Glu Gly Tyr Gly
Glu Tyr Gly Gly
Phe Asp Gly Ser
Phe Asp Ser Gly
Phe Gly Asp Ser
Phe Gly Ser Asp
Phe Ser Asp Gly
Phe Ser Gly Asp
Gly Ala Asp Tyr
Gly Ala Tyr Asp
Gly Asp Ala Tyr
Gly Asp Phe Ser
Gly Asp Ser Phe
Gly Asp Tyr Ala
Gly Glu Gly Tyr
Gly Glu Tyr Gly
Gly Phe Asp Ser
Gly Phe Ser Asp
Gly Gly Glu Tyr
Gly Gly Tyr Glu
Gly Met Met Ser
Gly Met Ser Met
Gly Ser Asp Phe
Gly Ser Phe Asp
Gly Ser Met Met
Gly Tyr Ala Asp
Gly Tyr Asp Ala
Gly Tyr Glu Gly
Gly Tyr Gly Glu
Ile Cys Cys Ser
Ile Cys Ser Cys
Ile Ser Cys Cys
Leu Cys Cys Ser
Leu Cys Ser Cys
Leu Ser Cys Cys
Met Ala Cys Thr
Met Ala Thr Cys
Met Cys Ala Thr
Met Cys Thr Ala
Met Gly Met Ser
Met Gly Ser Met
Met Met Gly Ser
Met Met Ser Gly
Met Ser Gly Met
Met Ser Met Gly
Met Thr Ala Cys
Met Thr Cys Ala
Ser Cys Cys Ile
Ser Cys Cys Leu
Ser Cys Ile Cys
Ser Cys Leu Cys
Ser Asp Phe Gly
Ser Asp Gly Phe
Ser Phe Asp Gly
Ser Phe Gly Asp
Ser Gly Asp Phe
Ser Gly Phe Asp
Ser Gly Met Met
Ser Ile Cys Cys
Ser Leu Cys Cys
Ser Met Gly Met
Ser Met Met Gly
Thr Ala Cys Met
Thr Ala Met Cys
Thr Cys Ala Met
Thr Cys Cys Val
Thr Cys Met Ala
Thr Cys Val Cys
Thr Met Ala Cys
Thr Met Cys Ala
Thr Val Cys Cys
Val Cys Cys Thr
Val Cys Thr Cys
Val Thr Cys Cys
Tyr Ala Asp Gly
Tyr Ala Gly Asp
Tyr Asp Ala Gly
Tyr Asp Gly Ala
Tyr Glu Gly Gly
Tyr Gly Ala Asp
Tyr Gly Asp Ala
Tyr Gly Glu Gly
Tyr Gly Gly Glu
3-Thiophenecarboxamide, 2-[(aminocarbonyl)amino]-5-[2-[2-[Methyl(phenylmethyl)amino]ethoxy]phenyl]-
Ethyl 4-acetoxy-5-(benzyloxy)-7,8-dimethoxy-2-naphthoate
4-[(5-carbamoyl-o-tolyl)azo]-3-hydroxynaphth-2-anilide
Darotropium bromide
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
4-{[1-Methyl-2,4-Dioxo-6-(3-Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2h)-Yl]methyl}benzoic Acid
N,N-[biphenyl-4,4-Diyldi(2r)propane-2,1-Diyl]dimethanesulfonamide
4-[bis(2-methoxyethyl)sulfamoyl]-N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)benzamide
6-Hydroxymelatonin glucuronide
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Diethyl (1r,2s,3r,4s)-5,6-Bis(4-Hydroxyphenyl)-7-Oxabicyclo[2.2.1]hept-5-Ene-2,3-Dicarboxylate
1-(3,4-dihydro-1H-isoquinolin-2-yl)-2-[[5-methyl-2-(4-methylphenyl)-4-oxazolyl]methylsulfonyl]ethanone
N-[2-(2-ethyl-1-piperidinyl)ethyl]-2-[(2-methyl-1,3-benzothiazol-6-yl)sulfonylamino]acetamide
Brasixanthone D
A member of the class of pyranoxanthones that is 2H,6H-pyrano[3,2-b]xanthen-6-one substituted by a 2-[(2S)-3,3-dimethyloxiran-2-yl]-2-hydroxyethyl group at position 12, hydroxy groups at positions 5 and 8 and geminal methyl groups at position 2. It is isolated from the stem bark of Calophyllum brasiliense and exhibits significant inhibitory activity against 12-O-tetradecanoylphorbol-13-acetate induced Epstein-Barr virus early antigen activation in Raji cells.
fumicycline A
An anthrafuran and meroterpenoid that is 2,3,11,11a-tetrahydroanthra[2,3-b]furan which is substituted by a 2-oxopropylidene group at position 2, a 3-methylbut-2-en-1-yl group at position 5, an oxo group at position 11, and hydroxy groups at positions 3a, 7, 9, and 10. It is one of the cryptic secondary metabolites (i.e. expressed at very low levels in the absence of specific triggers and/or conditions) of Aspergillus fumogatus, obtained following the induction of the fungus with the actinomycete Streptomyces rapamycinicus.
(5E)-N-[3-(ethylcarbamoyl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]-5-(3-methyl-6-oxocyclohexa-2,4-dien-1-ylidene)-1,2-dihydropyrazole-3-carboxamide
N-[(E)-(3-hydroxy-4-methoxyphenyl)methylideneamino]-4,6-diphenylpyrimidine-2-carboxamide
7,7-dimethyl-1-(4-methylphenyl)-2,5-dioxo-N-(2-oxo-3-thiolanyl)-6,8-dihydroquinoline-3-carboxamide
N-[2-(cyclohexylamino)-2-oxo-1-thiophen-2-ylethyl]-2,2,2-trifluoro-N-(4-methylphenyl)acetamide
(1S,5R)-7-[4-(3-methoxyphenyl)phenyl]-3-[(1-methyl-4-imidazolyl)sulfonyl]-3,6-diazabicyclo[3.1.1]heptane
N-[(2R,3S,6R)-6-[2-(4-cyclopropyl-1-triazolyl)ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-fluorobenzenesulfonamide
N-[(2S,3S,6R)-6-[2-(4-cyclopropyl-1-triazolyl)ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-fluorobenzenesulfonamide
N-[(2R,3S,6S)-6-[2-(4-cyclopropyl-1-triazolyl)ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-fluorobenzenesulfonamide
N-[(2S,3R,6S)-6-[2-(4-cyclopropyl-1-triazolyl)ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-fluorobenzenesulfonamide
N-[(2R,3R,6R)-6-[2-(4-cyclopropyl-1-triazolyl)ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-fluorobenzenesulfonamide
N-[(2S,3R,6R)-6-[2-(4-cyclopropyl-1-triazolyl)ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-fluorobenzenesulfonamide
N-[(2S,3S,6S)-6-[2-(4-cyclopropyl-1-triazolyl)ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-fluorobenzenesulfonamide
N-[(2R,3R,6S)-6-[2-(4-cyclopropyl-1-triazolyl)ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-fluorobenzenesulfonamide
N-[(Z)-(2-hydroxy-3-methoxyphenyl)methylideneamino]-4,6-diphenylpyrimidine-2-carboxamide
Eprosartan
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D057912 - Angiotensin II Type 2 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Eprosartan (SKF-108566J free base) is a selective, competitive, nonpeptid and orally active angiotensin II receptor antagonist, used as an antihypertensive. Eprosartan binds angiotensin II receptor with IC50s of 9.2 nM and 3.9 nM in rat and human adrenal cortical membranes, respectively [1].
RBC8
RBC8 is a novel small molecule inhibitor of Ral GTPase; has IC50 of 3.5 μM in H2122 cell and 3.4 μM in H358 cell. IC50 value: Target: Ral GTPase inhibitor RBC8 or BQU57 treatment showed no further inhibition of colony formation after Ral knockdown. RBC8 and BQU57 showed favorable properties that define good drug candidates. To test the effect of Ral inhibitors on xenograft tumor growth, nude mice were inoculated subcutaneously with H2122 human lung cancer cells and treated intraperitoneally with 50 mg/kg/d of RBC8 for 21 days (except weekends). RBC8 inhibited tumor growth to a similar extent as dual knockdown of RalA and RalB.
5,12-dihydroxy-6-methoxy-16,16-dimethyl-7-(3-methylbut-2-en-1-yl)-2,9,17-trioxatetracyclo[9.8.0.0³,⁸.0¹³,¹⁸]nonadeca-1(11),3,5,7,12,14,18-heptaen-10-one
3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl 2-methylbut-2-enoate
8-methoxy-14,14-dimethyl-6-oxo-4-phenyl-3,11,13-trioxatetracyclo[8.6.0.0²,⁷.0¹²,¹⁶]hexadeca-1(10),2(7),8-trien-15-yl acetate
4,12-bis[(2e)-but-2-en-2-yl]-6,14-dihydroxy-7,15-dimethyl-10-oxo-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaene-5-carboxylic acid
10,17,18-trimethoxy-7,7-dimethyl-2,8,21-trioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁵,²⁰]docosa-3,5,9,11,15(20),16,18-heptaen-13-one
1-(3,7-dimethyl-6-oxoocta-2,7-dien-1-yl)-3,6,8-trihydroxy-2-methoxyxanthen-9-one
5,7,9-trihydroxy-10-methoxy-2,2-dimethyl-12-(2-methylbut-3-en-2-yl)-1,11-dioxatetracen-6-one
methyl (2e,6e)-7-[2-(2-isopropyl-4,5-dihydro-1,3-thiazol-4-yl)-1,3-thiazol-4-yl]-3,5-dimethoxy-4-methylhepta-2,6-dienoate
4,12-bis(but-2-en-2-yl)-6,14-dihydroxy-7,15-dimethyl-10-oxo-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaene-5-carboxylic acid
(3r,6r)-3-[(4-{[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]oxy}phenyl)methyl]-1,4-dimethyl-3,6-bis(methylsulfanyl)piperazine-2,5-dione
3,6,8-trihydroxy-2-methoxy-1-(7-methyl-3-methylidene-2-oxooct-6-en-1-yl)xanthen-9-one
6-methoxy-8,8-dimethyl-3-(2,4,5-trimethoxyphenyl)pyrano[2,3-h]chromen-4-one
methyl 4-[(2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl)methyl]-2-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate
anticancer flavonoid pmv70p691-025
{"Ingredient_id": "HBIN016328","Ingredient_name": "anticancer flavonoid pmv70p691-025","Alias": "NA","Ingredient_formula": "C24H24O7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1403","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}